EP2773354
Samsetningar til notkunar um munn með tafarlausri losun fyrir setin kínasólínón
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
31.10.2012EP published:
12.6.2019EP application number:
12844794.3
EP translation filed:
3.7.2019Grant published:
15.7.2019EPO information:
European Patent Register
Max expiry date:
30.10.2032Expiry date:
30.10.2026Next due date:
31.10.2026
Title:
ORAL IMMEDIATE RELEASE FORMULATIONS FOR SUBSTITUTED QUINAZOLINONES
Timeline
Today
31.10.2012EP application
12.6.2019EP Publication
3.7.2019Translation submitted
15.7.2019Registration published
30.10.2026Expires
Owner
Name:
Resverlogix Corp.Address:
300, 4820 Richard Road SW, Calgary, AB T3E 6L1, CA
Inventor
Name:
SHENOY, Narmada, R.Address:
Sunnyvale, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161554090 PDate:
1.11.2011Country:
US
Classification
Categories:
A61K 9/48, A61K 31/517
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 9.9.2019
Expires: 30.10.2020
Payer: Árnason Faktor
Number: 9
Paid: 9.9.2020
Expires: 30.10.2021
Payer: Árnason Faktor ehf.
Number: 10
Paid: 7.9.2021
Expires: 30.10.2022
Payer: Árnason Faktor ehf.
Number: 11
Paid: 7.9.2022
Expires: 30.10.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 13.10.2023
Expires: 30.10.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 17.9.2024
Expires: 30.10.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 10.10.2025
Expires: 30.10.2026
Payer: Árnason Faktor ehf.